Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT00004256
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of laryngeal cancer with intention to treat by radiotherapy using a 16 fraction 3 week scheme
* Stage I or II
* No known CNS disease
PATIENT CHARACTERISTICS:
Age:
* 20 to 80
Performance status:
* WHO 0-1
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Hepatic function normal
Renal:
* Renal function normal
Other:
* Not pregnant or nursing
* No serious active infection requiring antibiotic therapy
* No autoimmune disease
* No known seizures
* No psychosocial factors that would preclude study compliance
* No allergies to sargramostim (GM-CSF)
* Willingness to cooperate for regular mirror examination of the larynx
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* No concurrent immunotherapy
Chemotherapy:
* No concurrent chemotherapy
Endocrine therapy:
* No prior or concurrent corticosteroids
* No concurrent hormonal therapy
Radiotherapy:
* See Disease Characteristics
Surgery:
* No major organ allografts
Other:
* No other concurrent investigational drugs
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT00004256
Study Brief:
Protocol Section:
NCT00004256